a notable trendp = 0.13
However, a notable trend towards increased discontinuations due to infection was observed for JAK inhibitors and anti-IL-6R antibodies in patients aged 65 years and older ( p = 0.13).
However, a notable trend towards increased discontinuations due to infection was observed for JAK inhibitors and anti-IL-6R antibodies in patients aged 65 years and older ( p = 0.13).